Novartis CEO: We’re moving toward filing Covid drug from Molecular Partners with FDA

0
60

Novartis CEO: We’re moving toward filing Covid drug from Molecular Partners with FDA

Novartis CEO Vas Narasimhan sits down with CNBC’s Meg Tirrell and the ‘Squawk on the Street’ team to discuss the company’s latest Covid-19 treatment, which it licensed from Molecular Partners.